Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Blood Clotting Cascade WP272,0.008150345521621152,250.28947368421052,1203.8160194534996,['SERPINE1'],0.17871651751896162,0,0,1
2,Ras signaling WP4223,0.011341771433553445,6.994047619047619,31.328177194210188,"['FLT1', 'RASAL3', 'RASGRP3']",0.17871651751896162,0,0,3
3,Selenium Micronutrient Network WP15,0.01205045947102809,13.12959112959113,58.01510052952792,"['SERPINE1', 'ALOX15B']",0.17871651751896162,0,0,2
4,p53 transcriptional gene network WP4963,0.01205045947102809,13.12959112959113,58.01510052952792,"['DRAM1', 'SERPINE1']",0.17871651751896162,0,0,2
5,Oncostatin M Signaling Pathway WP2374,0.016931957773489995,10.88556641748131,44.3973535839908,"['PRKCH', 'SERPINE1']",0.17871651751896162,0,0,2
6,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.020254707949243323,62.55263157894737,243.91573121652712,['CHI3L1'],0.17871651751896162,0,0,1
7,Pathways Regulating Hippo Signaling WP4540,0.024778765086301294,8.81081081081081,32.580336377109155,"['FLT1', 'PRKCH']",0.17871651751896162,0,0,2
8,Cytokines and Inflammatory Response WP530,0.028244203836257833,41.69298245614035,148.7133239372551,['IL15'],0.17871651751896162,0,0,1
9,Development and heterogeneity of the ILC family WP3893,0.032215112454179747,35.733082706766915,122.75455959315215,['IL15'],0.17871651751896162,0,0,1
10,Pyrimidine metabolism and related diseases WP4225,0.036170209985360725,31.263157894736842,103.77865999730463,['DPYD'],0.17871651751896162,0,0,1
11,RAS and bradykinin pathways in COVID-19 WP4969,0.036170209985360725,31.263157894736842,103.77865999730463,['SERPINE1'],0.17871651751896162,0,0,1
12,Biomarkers for pyrimidine metabolism disorders WP4584,0.04010955757701884,27.78654970760234,89.36545146830721,['DPYD'],0.17871651751896162,0,0,1
13,Urea cycle and metabolism of amino groups WP497,0.04010955757701884,27.78654970760234,89.36545146830721,['ARG2'],0.17871651751896162,0,0,1
14,7-oxo-C and 7beta-HC pathways WP5064,0.04403321618224248,25.00526315789474,78.086711263325,['ACOT11'],0.17871651751896162,0,0,1
15,Eicosanoid Synthesis WP167,0.04403321618224248,25.00526315789474,78.086711263325,['ALOX15B'],0.17871651751896162,0,0,1
16,TP53 network WP1742,0.04403321618224248,25.00526315789474,78.086711263325,['TNFSF10'],0.17871651751896162,0,0,1
17,Gastrin signaling pathway WP4659,0.04493530860020003,6.293626960293627,19.526175328349385,"['PRKCH', 'SERPINE1']",0.17871651751896162,0,0,2
18,Imatinib and Chronic Myeloid Leukemia WP3640,0.04794124654377487,22.729665071770334,69.04770032647413,['FLT1'],0.17871651751896162,0,0,1
19,Eicosanoid metabolism via lipooxygenases (LOX) WP4721,0.0518337092057934,20.833333333333332,61.66072051038615,['ALOX15B'],0.17871651751896162,0,0,1
20,Angiogenesis WP1539,0.059572172506320534,17.853383458646615,50.356659190737695,['FLT1'],0.17871651751896162,0,0,1
21,Oxysterols derived from cholesterol WP4545,0.059572172506320534,17.853383458646615,50.356659190737695,['ACOT11'],0.17871651751896162,0,0,1
22,Vitamin B12 metabolism WP1533,0.059572172506320534,17.853383458646615,50.356659190737695,['SERPINE1'],0.17871651751896162,0,0,1
23,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.059572172506320534,17.853383458646615,50.356659190737695,['SERPINE1'],0.17871651751896162,0,0,1
24,Fluoropyrimidine Activity WP1601,0.06341829316055742,16.66140350877193,45.95219958683752,['DPYD'],0.18232759283660258,0,0,1
25,miRNA regulation of p53 pathway in prostate cancer WP3982,0.07106461080078696,14.698142414860682,38.86432556262482,['SERPINE1'],0.18859454404824233,0,0,1
26,Complement and Coagulation Cascades WP558,0.07106461080078696,14.698142414860682,38.86432556262482,['SERPINE1'],0.18859454404824233,0,0,1
27,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.08991527596717637,11.351674641148325,27.344906354430822,['SERPINE1'],0.22978348302722848,0,0,1
28,Folate Metabolism WP176,0.09735072049835455,10.403508771929825,24.234298975866974,['SERPINE1'],0.23240629016715364,0,0,1
29,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.10104621311615376,9.986315789473684,22.89040647493055,['NOD1'],0.23240629016715364,0,0,1
30,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.10104621311615376,9.986315789473684,22.89040647493055,['PRKCH'],0.23240629016715364,0,0,1
31,TGF-beta Receptor Signaling WP560,0.119303672509093,8.317543859649122,17.683789986936382,['SERPINE1'],0.23558049292585145,0,0,1
32,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.119303672509093,8.317543859649122,17.683789986936382,['TNFSF10'],0.23558049292585145,0,0,1
33,Nuclear Receptors Meta-Pathway WP2882,0.12201614690600845,3.467604590892262,7.294459575743938,"['SLC6A6', 'CDC42EP3']",0.23558049292585145,0,0,2
34,Endochondral Ossification with Skeletal Dysplasias WP4808,0.12291156152653118,8.048387096774194,16.871754950111463,['SLC38A2'],0.23558049292585145,0,0,1
35,Endochondral Ossification WP474,0.12291156152653118,8.048387096774194,16.871754950111463,['SLC38A2'],0.23558049292585145,0,0,1
36,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.12291156152653118,8.048387096774194,16.871754950111463,['LIMD1'],0.23558049292585145,0,0,1
37,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.13364903620968271,7.335913312693498,14.76380465659885,['SERPINE1'],0.2492373918504894,0,0,1
38,Glucocorticoid Receptor Pathway WP2880,0.14073608291156797,6.926900584795321,13.58274389493981,['CDC42EP3'],0.25554709791837343,0,0,1
39,Rett syndrome causing genes WP4312,0.14776662997758044,6.5609418282548475,12.545315136340434,['CECR2'],0.2614332684218731,0,0,1
40,Synaptic Vesicle Pathway WP2267,0.1547411160243463,6.231578947368421,11.628137393242298,['STX3'],0.2669284251419974,0,0,1
41,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.1616599763722921,5.9335839598997495,10.812533067726097,['PRKCH'],0.27206191145580866,0,0,1
42,Apoptosis WP254,0.19211798805378247,4.881836945304437,8.053300712650836,['TNFSF10'],0.2938363831965586,0,0,1
43,Amino Acid metabolism WP3925,0.19543490072258576,4.787449392712551,7.815644912370453,['ARG2'],0.2938363831965586,0,0,1
44,Osteoblast differentiation WP4787,0.1987385429861879,4.696623634558093,7.588640896879767,['PRKCH'],0.2938363831965586,0,0,1
45,TYROBP causal network in microglia WP3945,0.1987385429861879,4.696623634558093,7.588640896879767,['DPYD'],0.2938363831965586,0,0,1
46,Pyrimidine metabolism WP4022,0.1987385429861879,4.696623634558093,7.588640896879767,['DPYD'],0.2938363831965586,0,0,1
47,Apoptosis Modulation and Signaling WP1772,0.20530622285356656,4.52488038277512,7.164028831581515,['TNFSF10'],0.2938363831965586,0,0,1
48,Pathways in clear cell renal cell carcinoma WP4018,0.20857036326564748,4.443609022556391,6.965263031566425,['FLT1'],0.2938363831965586,0,0,1
49,Wnt signaling pathway and pluripotency WP399,0.2118214388578575,4.365189289012004,6.774824538271345,['PRKCH'],0.2938363831965586,0,0,1
50,Prolactin Signaling Pathway WP2037,0.21505950060018117,4.2894736842105265,6.592237062441467,['CTSD'],0.2938363831965586,0,0,1
51,Hippo-Merlin Signaling Dysregulation WP4541,0.22469610884549646,4.077221742881795,6.087318225859494,['FLT1'],0.2938363831965586,0,0,1
52,NRF2 pathway WP2884,0.22788262042720928,4.0110356536502545,5.9320193208470355,['SLC6A6'],0.2938363831965586,0,0,1
53,Glioblastoma signaling pathways WP2261,0.22788262042720928,4.0110356536502545,5.9320193208470355,['PRKCH'],0.2938363831965586,0,0,1
54,Adipogenesis WP236,0.23421740689580756,3.8848684210526314,5.638907901932002,['SERPINE1'],0.2938363831965586,0,0,1
55,Genes related to primary cilium development (based on CRISPR) WP4536,0.23421740689580756,3.8848684210526314,5.638907901932002,['SCLT1'],0.2938363831965586,0,0,1
56,Senescence and Autophagy in Cancer WP615,0.24050154197521173,3.766347687400319,5.367153842188603,['SERPINE1'],0.29633225707660016,0,0,1
57,G Protein Signaling Pathways WP35,0.25291943265284567,3.549624060150376,4.87961242728271,['PRKCH'],0.3061656290008132,0,0,1
58,B Cell Receptor Signaling Pathway WP23,0.2860573673342385,3.0640025990903186,3.834791988305414,['RASGRP3'],0.34030962665624925,0,0,1
59,Ciliopathies WP4803,0.32337656658682434,2.6366181410974243,2.9765778678258408,['SCLT1'],0.375092285157088,0,0,1
60,Myometrial relaxation and contraction pathways WP289,0.3261672044844244,2.6085872576177285,2.9225180352364366,['PRKCH'],0.375092285157088,0,0,1
61,Calcium Regulation in the Cardiac Cell WP536,0.33171487706768393,2.554259359739555,2.8185727978919,['PRKCH'],0.37521846750279,0,0,1
62,Integrated breast cancer pathway WP1984,0.3587924710273716,2.3130841121495327,2.370936966001433,['RASGRP3'],0.392963182553788,0,0,1
63,Focal Adhesion WP306,0.3587924710273716,2.3130841121495327,2.370936966001433,['FLT1'],0.392963182553788,0,0,1
64,Circadian rhythm related genes WP3594,0.3771075842829862,2.16943674976916,2.1156884396888085,['SERPINE1'],0.40656911430509446,0,0,1
65,Insulin Signaling WP481,0.40239059974547314,1.9923599320882852,1.8137090434236753,['PRKCH'],0.4271530981913484,0,0,1
66,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.4701880619467822,1.609735122119023,1.2147423945201292,['FLT1'],0.4881686566808617,0,0,1
67,PI3K-Akt signaling pathway WP4172,0.4767579774919851,1.5782726045883941,1.1690995947177811,['FLT1'],0.4881686566808617,0,0,1
68,MAPK Signaling Pathway WP382,0.4810937486130231,1.5579613590939374,1.1399496143838215,['RASGRP3'],0.4881686566808617,0,0,1
69,VEGFA-VEGFR2 Signaling Pathway WP3888,0.7415175450012084,0.7462638076673165,0.2231750097004732,['FLT1'],0.7415175450012084,0,0,1
